These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37424473)

  • 21. Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease.
    Cuesta M; Aungier J; Morton AJ
    Neurobiol Dis; 2014 Mar; 63():85-91. PubMed ID: 24269914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.
    Kudo T; Schroeder A; Loh DH; Kuljis D; Jordan MC; Roos KP; Colwell CS
    Exp Neurol; 2011 Mar; 228(1):80-90. PubMed ID: 21184755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease.
    Bartlett DM; Domínguez D JF; Reyes A; Zaenker P; Feindel KW; Newton RU; Hannan AJ; Slater JA; Eastwood PR; Lazar AS; Ziman M; Cruickshank T
    Neurobiol Sleep Circadian Rhythms; 2019 Jan; 6():1-8. PubMed ID: 31236517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How vital is sleep in Huntington's disease?
    Goodman AO; Barker RA
    J Neurol; 2010 Jun; 257(6):882-97. PubMed ID: 20333394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant huntingtin disturbs circadian clock gene expression and sleep patterns in Drosophila.
    Faragó A; Zsindely N; Bodai L
    Sci Rep; 2019 May; 9(1):7174. PubMed ID: 31073199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.
    Loh DH; Kudo T; Truong D; Wu Y; Colwell CS
    PLoS One; 2013; 8(7):e69993. PubMed ID: 23936129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.
    Smarr B; Cutler T; Loh DH; Kudo T; Kuljis D; Kriegsfeld L; Ghiani CA; Colwell CS
    J Neurosci Res; 2019 Dec; 97(12):1606-1623. PubMed ID: 31359503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding.
    Maywood ES; Fraenkel E; McAllister CJ; Wood N; Reddy AB; Hastings MH; Morton AJ
    J Neurosci; 2010 Jul; 30(30):10199-204. PubMed ID: 20668203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian Rhythms, Sleep, and Disorders of Aging.
    Mattis J; Sehgal A
    Trends Endocrinol Metab; 2016 Apr; 27(4):192-203. PubMed ID: 26947521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.
    van Wamelen DJ; Aziz NA; Roos RA; Swaab DF
    J Neuroendocrinol; 2014 Nov; 26(11):761-75. PubMed ID: 25074766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian Interventions in Preclinical Models of Huntington's Disease: A Narrative Review.
    Dell'Angelica D; Singh K; Colwell CS; Ghiani CA
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.
    Zhang Y; Ren R; Yang L; Zhou J; Li Y; Shi J; Lu L; Sanford LD; Tang X
    Sleep; 2019 Oct; 42(10):. PubMed ID: 31328779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
    Ouk K; Aungier J; Morton AJ
    Exp Neurol; 2016 Dec; 286():69-82. PubMed ID: 27646506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of saccadic abnormalities with rem sleep in patients with Huntington's disease.
    Annapureddy J; Ray S; Kamble N; Kumar G; Pal PK; Dv S; Jain S; Kutty B; Yadav R
    Sleep Med; 2022 May; 93():84-89. PubMed ID: 34852959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep Dysfunction in Huntington's Disease: Perspectives from Patients.
    Tanigaki WK; Rossetti MA; Rocha NP; Stimming EF
    J Huntingtons Dis; 2020; 9(4):345-352. PubMed ID: 32986678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep disturbances by disease type and stage in Huntington's disease.
    Ogilvie AC; Nopoulos PC; Schultz JL
    Parkinsonism Relat Disord; 2021 Oct; 91():13-18. PubMed ID: 34450461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.
    Hurelbrink CB; Lewis SJ; Barker RA
    J Neurol; 2005 Jun; 252(6):642-7. PubMed ID: 15742112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington's Disease Mice.
    Lebreton F; Cayzac S; Pietropaolo S; Jeantet Y; Cho YH
    PLoS One; 2015; 10(5):e0126972. PubMed ID: 25966356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed onset of the diurnal melatonin rise in patients with Huntington's disease.
    Aziz NA; Pijl H; Frölich M; Schröder-van der Elst JP; van der Bent C; Roelfsema F; Roos RA
    J Neurol; 2009 Dec; 256(12):1961-5. PubMed ID: 19562249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormally abrupt transitions from sleep-to-wake in Huntington's disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics.
    Schneider WT; Vas S; Nicol AU; Morton AJ
    PLoS One; 2021; 16(5):e0251767. PubMed ID: 33984047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.